CC
LLY icon

Centiva Capital’s Eli Lilly LLY Stock Holding History

Centiva Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.5M Sell
7,922
-2,955
-27% -$3.02M 0.08% 177
2026
Q1 		$10M Sell
10,877
-11,996
-52% -$12.2M 0.07% 176
2025
Q4 		$24.6M Sell
22,873
-16,009
-41% -$15.3M 0.2% 87
2025
Q3 		$29.7M Buy
38,882
+38,413
+8,190% +$28.6M 0.28% 64
2025
Q2 		$366K Sell
469
-1,883
-80% -$1.46M 0.01% 1102
2025
Q1 		$1.94M Sell
2,352
-281
-11% -$234K 0.06% 194
2024
Q4 		$2.03M Sell
2,633
-24,193
-90% -$20M 0.04% 326
2024
Q3 		$23.8M Buy
26,826
+26,649
+15,056% +$24M 0.47% 27
2024
Q2 		$160K Sell
177
-1,680
-90% -$1.34M ﹤0.01% 1754
2024
Q1 		$1.44M Sell
1,857
-1,316
-41% -$937K 0.04% 484
2023
Q4 		$1.85M Buy
3,173
+2,149
+210% +$1.25M 0.04% 380
2023
Q3 		$550K Sell
1,024
-2,439
-70% -$1.26M 0.01% 920
2023
Q2 		$1.62M Buy
+3,463
New +$1.45M 0.04% 444
2021
Q4 		– Sell
-1,017
Closed -$258K – 1390
2021
Q3 		$235K Sell
1,017
-1,648
-62% -$407K 0.01% 869
2021
Q2 		$612K Sell
2,665
-460
-15% -$92.4K 0.01% 749
2021
Q1 		$584K Sell
3,125
-2,865
-48% -$560K 0.02% 506
2020
Q4 		$1.01M Sell
5,990
-18,773
-76% -$2.8M 0.04% 271
2020
Q3 		$3.67M Buy
24,763
+17,405
+237% +$2.69M 0.24% 69
2020
Q2 		$1.21M Sell
7,358
-8,418
-53% -$1.29M 0.07% 150
2020
Q1 		$2.19M Sell
15,776
-1,243
-7% -$171K 0.1% 134
2019
Q4 		$2.24M Buy
17,019
+13,208
+347% +$1.53M 0.11% 183
2019
Q3 		$426K Buy
+3,811
New +$424K 0.03% 363
2019
Q2 		– Sell
-1
Closed -$118 – 476
2019
Q1 		$0 Sell
1
-26,116
-100% -$3.18M ﹤0.01% 345
2018
Q4 		$3.02M Buy
+26,117
New +$2.92M 0.24% 58

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centiva Capital's LLY Position: Q2 2026 in Review

Centiva Capital reduced its Eli Lilly (LLY) stake by 27% in Q2 2026, selling an estimated $3.02M and leaving 7,922 shares worth $9.5M. The position accounts for 0.08% of the portfolio, ranked #177.

Centiva Capital first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $29.7M in Q3 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Centiva Capital held 7,922 shares of Eli Lilly worth $9.5M as of Q2 2026.
  • Centiva Capital sold 2,955 Eli Lilly shares in Q2 2026, an estimated $3.02M.
  • Eli Lilly made up 0.08% of Centiva Capital's portfolio in Q2 2026, its #177 holding.
  • Centiva Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
  • Centiva Capital's Eli Lilly position peaked at $29.7M in Q3 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.